Komori
Share Issuance and Disposal8750Daiichi Life Group,Inc.Financials (excluding banks)

Issuance of New Shares under the Share-Based Compensation Plan

The Board of Directors resolved to issue 269,800 common shares as restricted stock-based compensation (RS) and 473,000 common shares as performance share units (PSUs) to directors and executive officers. The payment date is 13 July 2026.

Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
742800
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares as restricted stock compensation, Issuance of new shares as performance share units

Who receives how much

RS 269,800 shares / PSU 473,000 shares

The CompanyRS: 119,800 shares
The Dai-ichi Life Insurance Company, LimitedRS: 100,400 shares
The Dai-ichi Frontier Life Insurance Co., Ltd.RS: 18,000 shares; PSU: 45,200 shares
Dai-ichi Neo Life Insurance Co., Ltd.RS: 4,000 shares
Dai-ichi Life Insurance Company, LimitedRS: 3,600 shares; PSU: 15,500 shares
Vertex Investment Solutions Co., Ltd.RS: 4,000 shares
Benefit One Inc.RS: 10,500 shares; PSU: 14,400 shares
Dai-ichi Life Technocross Co., Ltd.RS: 3,600 shares
QOLead Inc.RS: 2,800 shares; PSU: 12,300 shares
Dai-ichi Life Bussan Co., Ltd.RS: 3,100 shares

The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.

¥1,814.5 per share
Total issue value

RS ¥489,552,100 / PSU ¥858,258,500

Amount of funds to be raised
Total payment amount ¥1,347,810,600 / Estimated net proceeds Not disclosed
Total Stock-Based Compensation
RS ¥489,552,100 / PSU ¥858,258,500
発行済株式総数

Less than 0.1% for both RS and PSU

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
3 years (from 13 July 2026 to 12 July 2029, or until the later of these dates or the date on which the prescribed semiannual securities report is filed)
Conditions for lifting transfer restrictions
For RS recipients, all transfer restrictions will be lifted upon expiry of the transfer restriction period, provided that the recipient has continuously held the position of director or executive officer of the Company or an eligible group company throughout the transfer restriction period. In the event of retirement or resignation for a legitimate reason, such as expiry of the term of office or reaching retirement age, the restrictions will be lifted at the prescribed time. For PSUs, the number of shares to be delivered will be calculated according to the degree of achievement of performance targets and other factors during the performance evaluation period, subject to continued service and the absence of serious misconduct, among other conditions.
Reason for acquisition without consideration
For RS, all shares will be acquired without consideration if the recipient becomes subject to an event specified in the agreement, such as being sentenced to imprisonment or a more severe penalty during the transfer restriction period, except where the sentence is suspended. All or part of the shares may be acquired without consideration if the Board of Directors deems this appropriate in cases such as a material violation of laws or regulations. Shares for which the transfer restrictions have not been lifted in connection with a corporate reorganization or similar event will also be acquired without consideration. For PSUs, the recipient will forfeit the right to receive the shares in cases such as attachment, a material violation of laws, regulations or internal rules, or engaging in competitive activities.
Stock Split Ratio4-for-1 stock split, effective 1 April 2025
Categories and Number of Persons Covered
RS: 4 directors and 21 executive officers of the Company; 5 directors and 22 executive officers of Dai-ichi Life Insurance Company, Limited; 4 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Neo Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Vertex Investment Solutions Co., Ltd.; 3 directors of Benefit One Inc.; 1 director of Dai-ichi Life Technocross Co., Ltd.; 1 director of QOLead Inc.; and 1 director of Dai-ichi Life Bussan Co., Ltd., PSU: 3 directors and 14 executive officers of the Company; 3 directors and 14 executive officers of Dai-ichi Life Insurance Company, Limited; 3 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Benefit One Inc.; and 1 director of QOLead Inc.
Payment date
13 July 2026
Basis for determining the amount to be paid
The closing price of the Company's common stock on the Prime Market of the Tokyo Stock Exchange on 19 June 2026, ¥1,814.5. No discount or premium.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares as restricted stock compensation, Issuance of new shares as performance share units
Number of shares to be issued or disposed ofRS 269,800 shares / PSU 473,000 shares
Issue price and disposal price¥1,814.5 per share
Total issue valueRS ¥489,552,100 / PSU ¥858,258,500
Amount of funds to be raisedTotal payment amount ¥1,347,810,600 / Estimated net proceeds Not disclosed
Payment date13 July 2026
Intended allotteeName The Company / Category 4 directors and 21 executive officers / Number of Shares RS: 119,800 shares, Name The Dai-ichi Life Insurance Company, Limited / Category 5 directors and 22 executive officers / Number of Shares RS: 100,400 shares, Name The Dai-ichi Frontier Life Insurance Co., Ltd. / Category 4 directors / Number of Shares RS: 18,000 shares; PSU: 45,200 shares, Name Dai-ichi Neo Life Insurance Co., Ltd. / Category 1 director / Number of Shares RS: 4,000 shares, Name Dai-ichi Life Insurance Company, Limited / Category 1 director / Number of Shares RS: 3,600 shares; PSU: 15,500 shares, Name Vertex Investment Solutions Co., Ltd. / Category 1 director / Number of Shares RS: 4,000 shares, Name Benefit One Inc. / Category 3 directors / Number of Shares RS: 10,500 shares; PSU: 14,400 shares, Name Dai-ichi Life Technocross Co., Ltd. / Category 1 director / Number of Shares RS: 3,600 shares, Name QOLead Inc. / Category 1 director / Number of Shares RS: 2,800 shares; PSU: 12,300 shares, Name Dai-ichi Life Bussan Co., Ltd. / Category 1 director / Number of Shares RS: 3,100 shares
Dilution RateLess than 0.1% for both RS and PSU
Basis for determining the amount to be paidThe closing price of the Company's common stock on the Prime Market of the Tokyo Stock Exchange on 19 June 2026, ¥1,814.5. No discount or premium.
Transfer restriction period3 years (from 13 July 2026 to 12 July 2029, or until the later of these dates or the date on which the prescribed semiannual securities report is filed)
Conditions for lifting transfer restrictionsFor RS recipients, all transfer restrictions will be lifted upon expiry of the transfer restriction period, provided that the recipient has continuously held the position of director or executive officer of the Company or an eligible group company throughout the transfer restriction period. In the event of retirement or resignation for a legitimate reason, such as expiry of the term of office or reaching retirement age, the restrictions will be lifted at the prescribed time. For PSUs, the number of shares to be delivered will be calculated according to the degree of achievement of performance targets and other factors during the performance evaluation period, subject to continued service and the absence of serious misconduct, among other conditions.
Reason for acquisition without considerationFor RS, all shares will be acquired without consideration if the recipient becomes subject to an event specified in the agreement, such as being sentenced to imprisonment or a more severe penalty during the transfer restriction period, except where the sentence is suspended. All or part of the shares may be acquired without consideration if the Board of Directors deems this appropriate in cases such as a material violation of laws or regulations. Shares for which the transfer restrictions have not been lifted in connection with a corporate reorganization or similar event will also be acquired without consideration. For PSUs, the recipient will forfeit the right to receive the shares in cases such as attachment, a material violation of laws, regulations or internal rules, or engaging in competitive activities.
Categories and Number of Persons CoveredRS: 4 directors and 21 executive officers of the Company; 5 directors and 22 executive officers of Dai-ichi Life Insurance Company, Limited; 4 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Neo Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Vertex Investment Solutions Co., Ltd.; 3 directors of Benefit One Inc.; 1 director of Dai-ichi Life Technocross Co., Ltd.; 1 director of QOLead Inc.; and 1 director of Dai-ichi Life Bussan Co., Ltd., PSU: 3 directors and 14 executive officers of the Company; 3 directors and 14 executive officers of Dai-ichi Life Insurance Company, Limited; 3 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Benefit One Inc.; and 1 director of QOLead Inc.
Total Stock-Based CompensationRS ¥489,552,100 / PSU ¥858,258,500
Stock Split Ratio4-for-1 stock split, effective 1 April 2025
Items this document does not state (13)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To increase the motivation and morale of directors and executive officers to contribute to enhancing shareholder value through the sustainable growth of corporate value, promote value sharing with shareholders, and provide incentives to achieve performance targets and improve performance over the medium to long term.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Issuance of New Shares under the Share-Based Compensation Plan | Daiichi Life Group,Inc. (8750) timely disclosure | Komori